BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 23153581)

  • 1. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.
    Jansen SM; Sleumer LS; Damen E; Meijer IM; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2009 May; 21(5):810-8. PubMed ID: 19263517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Usp8 deubiquitination enzyme is post-translationally modified by tyrosine and serine phosphorylation.
    Meijer IM; Kerperien J; Sotoca AM; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Apr; 25(4):919-30. PubMed ID: 23333852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERBB2 is a target for USP8-mediated deubiquitination.
    Meijer IM; van Leeuwen JE
    Cell Signal; 2011 Feb; 23(2):458-67. PubMed ID: 21044682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
    Smith CJ; Berry DM; McGlade CJ
    J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling.
    Azakir BA; Angers A
    Cell Signal; 2009 Aug; 21(8):1326-36. PubMed ID: 19341794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms.
    Sundvall M; Korhonen A; Paatero I; Gaudio E; Melino G; Croce CM; Aqeilan RI; Elenius K
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4162-7. PubMed ID: 18334649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells.
    Zeng F; Xu J; Harris RC
    FASEB J; 2009 Jun; 23(6):1935-45. PubMed ID: 19193720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine 63-linked polyubiquitination is required for EGF receptor degradation.
    Huang F; Zeng X; Kim W; Balasubramani M; Fortian A; Gygi SP; Yates NA; Sorkin A
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15722-7. PubMed ID: 24019463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
    Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
    Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
    Sehat B; Andersson S; Girnita L; Larsson O
    Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation.
    Umebayashi K; Stenmark H; Yoshimori T
    Mol Biol Cell; 2008 Aug; 19(8):3454-62. PubMed ID: 18508924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
    Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
    Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.
    Soubeyran P; Kowanetz K; Szymkiewicz I; Langdon WY; Dikic I
    Nature; 2002 Mar; 416(6877):183-7. PubMed ID: 11894095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.
    Grøvdal LM; Stang E; Sorkin A; Madshus IH
    Exp Cell Res; 2004 Nov; 300(2):388-95. PubMed ID: 15475003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.
    Haglund K; Shimokawa N; Szymkiewicz I; Dikic I
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12191-6. PubMed ID: 12218189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chimeric pre-ubiquitinated EGF receptor is constitutively endocytosed in a clathrin-dependent, but kinase-independent manner.
    Bertelsen V; Sak MM; Breen K; Rødland MS; Johannessen LE; Traub LM; Stang E; Madshus IH
    Traffic; 2011 Apr; 12(4):507-20. PubMed ID: 21226813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation.
    Stern KA; Visser Smit GD; Place TL; Winistorfer S; Piper RC; Lill NL
    Mol Cell Biol; 2007 Feb; 27(3):888-98. PubMed ID: 17101784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
    Visser GD; Lill NL
    Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.